(Q30397509)

21 June 2017

1 reference

title

Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant (English)

1 reference

21 June 2017

1 reference

Susan M Abdel-Rahman

1

1 reference

21 June 2017

Jason G Newland

series ordinal

2

1 reference

21 June 2017

Gregory L Kearns

series ordinal

3

1 reference

21 June 2017

publication date

1 February 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

13

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

19-31

1 reference

Thyroid hormone regulates the activity and expression of the peptide transporter PEPT1 in Caco-2 cells

21 June 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11536950-000000000-00000

Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate

21 January 2018

1 reference

12 December 2020

Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine.

1 reference

12 December 2020

P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier.

1 reference

12 December 2020

Intestinal peptide transporter PepT1 is over-expressed during acute cryptosporidiosis in suckling rats as a result of both malnutrition and experimental parasite infection

1 reference

12 December 2020

Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years

1 reference

12 December 2020

Diurnal expression and function of peptide transporter 1 (PEPT1)

1 reference

12 December 2020

Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

1 reference

12 December 2020

Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures

1 reference

12 December 2020

Distribution of the H+/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome

1 reference

12 December 2020

A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination

1 reference

12 December 2020

Functional and molecular expression of intestinal oligopeptide transporter (Pept-1) after a brief fast.

1 reference

12 December 2020

Parietal Cell Secretory Function in Early Childhood

1 reference

12 December 2020

Effect of lipopolysaccharide on peptide transporter 1 expression in rat small intestine and its attenuation by dexamethasone

1 reference

12 December 2020

The regionalization of PepT1, NBAT and EAAC1 transporters in the small intestine of rats are unchanged from birth to adulthood.

1 reference

12 December 2020

Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes

1 reference

12 December 2020

Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney.

1 reference

12 December 2020

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.

1 reference

12 December 2020

Influenza-associated hospitalizations in the United States

1 reference

12 December 2020

Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans

1 reference

12 December 2020

Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids

1 reference

12 December 2020

Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system

1 reference

12 December 2020

Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic a

1 reference

12 December 2020

Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules.

1 reference

12 December 2020

Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin

1 reference

12 December 2020

Diurnal rhythm of H+-peptide cotransporter in rat small intestine

1 reference

12 December 2020

Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney

1 reference

12 December 2020

Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters

1 reference

12 December 2020

Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel.

1 reference

12 December 2020

Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

12 December 2020

In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations

1 reference

12 December 2020

Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season

1 reference

12 December 2020

Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics.

1 reference

12 December 2020

Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits

1 reference

12 December 2020

ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS

1 reference

12 December 2020

Importance of collection tube during clinical studies of oseltamivir

1 reference

12 December 2020

The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology

1 reference

12 December 2020

Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil.

1 reference

12 December 2020

Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.

1 reference

12 December 2020

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases

1 reference

12 December 2020

Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).

1 reference

12 December 2020

The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene

1 reference

12 December 2020

Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules

1 reference

12 December 2020

Pharmacokinetics and tolerability of oseltamivir combined with probenecid.

1 reference

12 December 2020

Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development

1 reference

12 December 2020

The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers.

1 reference

12 December 2020

1 reference

12 December 2020

Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney

1 reference

12 December 2020

Oseltamivir (tamiflu) is a substrate of peptide transporter 1.

1 reference

12 December 2020

The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain

1 reference

12 December 2020

Oseltamivir dosing for influenza infection in premature neonates

1 reference

12 December 2020

Molecular cloning, distribution and ontogenetic expression of the oligopeptide transporter PepT1 mRNA in Tibetan suckling piglets

1 reference

12 December 2020

Growth factors regulation of rabbit sodium-dependent neutral amino acid transporter ATB0 and oligopeptide transporter 1 mRNAs expression after enteretomy

1 reference

12 December 2020

Population pharmacokinetics of oseltamivir when coadministered with probenecid

1 reference

12 December 2020

Protein content of infant formula--how much and from what age?

1 reference

12 December 2020

High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.

1 reference

12 December 2020

The mammalian carboxylesterases: from molecules to functions.

1 reference

12 December 2020

Dipeptide Transport in the Intestinal Mucosa of Developing Rabbits

1 reference

12 December 2020

Pharmacogenomic assessment of carboxylesterases 1 and 2

1 reference

12 December 2020

Analysis of oseltamivir active metabolite, oseltamivir carboxylate, in biological materials by HPLC-UV in a case of death following ingestion of Tamiflu

1 reference

12 December 2020

Observations on the gastric acidity during the first month of life

1 reference

12 December 2020

Comparative carboxylesterase activities in infant and adult liver and their in vitro sensitivity to chlorpyrifos oxon

1 reference

12 December 2020

Developmental changes in multispecific organic anion transporter 1 expression in the rat kidney.

1 reference

12 December 2020

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

12 December 2020

Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2.

1 reference

12 December 2020

Regulation of PepT1 peptide transporter expression in the rat small intestine under malnourished conditions

1 reference

12 December 2020

Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants

1 reference

12 December 2020

Multidrug resistance gene (P-glycoprotein) expression in the human fetus

1 reference

12 December 2020

Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites

1 reference

12 December 2020

Substrate upregulation of the human small intestinal peptide transporter, hPepT1

1 reference

12 December 2020

Pharmacokinetics of oseltamivir in young and very elderly subjects.

1 reference

12 December 2020

Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children

1 reference

12 December 2020

Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers

1 reference

12 December 2020

Developmental pharmacology--drug disposition, action, and therapy in infants and children

1 reference

12 December 2020

Cytokines in the pathogenesis of influenza

1 reference

12 December 2020

Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct

1 reference

12 December 2020

Pharmacokinetics of high-dose oseltamivir in healthy volunteers

1 reference

12 December 2020

Developmental expression of PEPT1 and PEPT2 in rat small intestine, colon, and kidney.

1 reference

12 December 2020

Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.

1 reference

12 December 2020

Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2.

1 reference

12 December 2020

Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1).

1 reference

12 December 2020

Cellular and molecular mechanisms of dietary regulation on rat intestinal H+/Peptide transporter PepT1.

1 reference

12 December 2020

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

12 December 2020

Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney

1 reference

12 December 2020

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

12 December 2020

Influenza B infection associated with encephalitis: treatment with oseltamivir

1 reference

12 December 2020

Age-dependent change in intestinal absorption of dipeptides and their constituent amino acids in the guinea pig.

1 reference

12 December 2020

Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein.

1 reference

12 December 2020

Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs

1 reference

12 December 2020

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

1 reference

12 December 2020

Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2

1 reference

12 December 2020

10.2165/11536950-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1008120872

0 references

1 reference